CapsoVision Inc. is a commercial-stage medical technology company specializing in the development of advanced imaging and artificial intelligence-driven solutions for capsule endoscopy. Its core innovations are designed to empower physicians and streamline clinical operations by enhancing the detection and diagnosis of abnormalities within the gastrointestinal tract. CapsoVision’s flagship product, the CapsoCam Plus®, is a small bowel capsule endoscope that offers a 360° panoramic lateral view—a unique feature in the field—alongside a wire-free design for enhanced patient comfort. The company’s offerings also include products and cloud-based services such as CapsoCloud® for efficient image review and analysis, and solutions for colon visualization and polyp detection. CapsoVision addresses critical needs in the healthcare sector, particularly for gastrointestinal specialists and hospital systems seeking noninvasive diagnostic tools. Its role in the market is defined by its commitment to improving patient care, driving innovation in medical devices, and supporting better clinical outcomes through cutting-edge technology. Annual revenue is reported in the low eight figures, with a growing presence in the medical equipment manufacturing and diagnostic equipment industries.